$TDOC
Teladoc Health, Inc.

2019 Q3 Form 10-Q Financial Statement

#000155837019006664 Filed on July 31, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $138.0M $130.3M $94.56M
YoY Change 24.34% 37.77% 112.02%
Cost Of Revenue $42.80M $41.63M $27.68M
YoY Change 25.26% 50.39% 176.84%
Gross Profit $95.17M $88.64M $66.88M
YoY Change 23.93% 32.55% 93.28%
Gross Profit Margin 68.98% 68.04% 70.72%
Selling, General & Admin $54.80M $54.38M $40.70M
YoY Change 17.56% 33.62% 10.9%
% of Gross Profit 57.58% 61.35% 60.86%
Research & Development $15.75M $16.67M $14.35M
YoY Change 15.98% 16.15% 91.31%
% of Gross Profit 16.55% 18.8% 21.45%
Depreciation & Amortization $11.42M $10.88M $8.050M
YoY Change 17.13% 35.16% 201.5%
% of Gross Profit 12.0% 12.27% 12.04%
Operating Expenses $70.55M $71.05M $55.05M
YoY Change 17.2% 29.06% 17.12%
Operating Profit -$19.94M -$22.02M -$18.15M
YoY Change 26.4% 21.36% 46.35%
Interest Expense -$7.700M -$7.200M -$6.900M
YoY Change 0.0% 4.35% 762.5%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$27.64M -$29.23M -$25.06M
YoY Change 17.92% 16.67% 63.77%
Income Tax -$7.300M $100.0K $22.00K
% Of Pretax Income
Net Earnings -$20.35M -$29.32M -$25.08M
YoY Change -12.54% 16.93% 62.85%
Net Earnings / Revenue -14.75% -22.51% -26.52%
Basic Earnings Per Share
Diluted Earnings Per Share -$281.2K -$408.6K -$398.4K
COMMON SHARES
Basic Shares Outstanding 72.04M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $490.9M $472.6M $132.0M
YoY Change 3.78% 258.03% -70.0%
Cash & Equivalents $475.2M $440.4M $105.8M
Short-Term Investments $15.63M $32.16M $27.00M
Other Short-Term Assets $13.00M $10.00M $8.000M
YoY Change 18.18% 25.0% 300.0%
Inventory
Prepaid Expenses
Receivables $53.70M $49.80M $38.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $558.0M $532.6M $179.0M
YoY Change 6.68% 197.55% -60.83%
LONG-TERM ASSETS
Property, Plant & Equipment $10.02M $9.722M $10.00M
YoY Change 0.21% -2.78% 42.86%
Goodwill $737.6M $748.1M
YoY Change
Intangibles $228.8M $239.3M
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.367M $6.376M $1.000M
YoY Change 536.7% 537.6%
Total Long-Term Assets $1.010B $1.033B $1.021B
YoY Change -0.15% 1.15% 370.51%
TOTAL ASSETS
Total Short-Term Assets $558.0M $532.6M $179.0M
Total Long-Term Assets $1.010B $1.033B $1.021B
Total Assets $1.568B $1.565B $1.200B
YoY Change 2.18% 30.45% 78.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.068M $6.079M $6.000M
YoY Change 21.36% 1.32% 500.0%
Accrued Expenses $54.00M $38.00M $38.00M
YoY Change 42.11% 0.0% 192.31%
Deferred Revenue $14.36M $12.29M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $85.20M $70.42M $57.00M
YoY Change 46.9% 23.55% 185.0%
LONG-TERM LIABILITIES
Long-Term Debt $434.0M $427.0M $403.0M
YoY Change 6.11% 5.96% 65.16%
Other Long-Term Liabilities $7.156M $6.990M $6.000M
YoY Change 19.27% 16.5% -33.33%
Total Long-Term Liabilities $7.156M $6.990M $409.0M
YoY Change -98.28% -98.29% 61.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.20M $70.42M $57.00M
Total Long-Term Liabilities $7.156M $6.990M $409.0M
Total Liabilities $92.36M $77.41M $501.0M
YoY Change -81.78% -84.55% 82.18%
SHAREHOLDERS EQUITY
Retained Earnings -$488.5M -$468.1M
YoY Change
Common Stock $1.510B $1.483B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $993.7M $1.003B $699.4M
YoY Change
Total Liabilities & Shareholders Equity $1.568B $1.565B $1.200B
YoY Change 2.18% 30.45% 78.04%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$20.35M -$29.32M -$25.08M
YoY Change -12.54% 16.93% 62.85%
Depreciation, Depletion And Amortization $11.42M $10.88M $8.050M
YoY Change 17.13% 35.16% 201.5%
Cash From Operating Activities $13.49M $6.150M -$3.650M
YoY Change 32.51% -268.49% 25.43%
INVESTING ACTIVITIES
Capital Expenditures -$3.290M -$2.550M -$2.370M
YoY Change 57.42% 7.59% 192.59%
Acquisitions
YoY Change
Other Investing Activities $16.47M -$2.510M -$237.2M
YoY Change 545.88% -98.94% -4901.82%
Cash From Investing Activities $13.20M -$5.070M -$239.6M
YoY Change 2769.57% -97.88% -5900.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.150M 5.200M 284.6M
YoY Change -97.32% -98.17% 6.17%
NET CHANGE
Cash From Operating Activities 13.49M 6.150M -3.650M
Cash From Investing Activities 13.20M -5.070M -239.6M
Cash From Financing Activities 9.150M 5.200M 284.6M
Net Change In Cash 35.84M 6.280M 41.38M
YoY Change -89.82% -84.82% -84.63%
FREE CASH FLOW
Cash From Operating Activities $13.49M $6.150M -$3.650M
Capital Expenditures -$3.290M -$2.550M -$2.370M
Free Cash Flow $16.78M $8.700M -$1.280M
YoY Change 36.76% -779.69% -39.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001477449
tdoc Number Of Service Corporations Consolidated As Variable Interest Entities
NumberOfServiceCorporationsConsolidatedAsVariableInterestEntities
1
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70516249
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71934381
CY2018Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2018Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37477
dei Entity Registrant Name
EntityRegistrantName
TELADOC HEALTH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3705970
dei Entity Address Address Line1
EntityAddressAddressLine1
2 Manhattanville Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 203
dei Entity Address City Or Town
EntityAddressCityOrTown
Purchase
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10577
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
635-2002
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
TDOC
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
72040539
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
440443000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
423989000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
32161000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
54545000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3351000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3382000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49778000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43571000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10227000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10631000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
532609000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
532736000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9722000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10148000
CY2019Q2 us-gaap Goodwill
Goodwill
748073000
CY2018Q4 us-gaap Goodwill
Goodwill
737197000
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
239344000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
247394000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29220000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6376000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1401000
CY2019Q2 us-gaap Assets
Assets
1565344000
CY2018Q4 us-gaap Assets
Assets
1528876000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6079000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7769000
CY2019Q2 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
46201000
CY2018Q4 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
26801000
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18141000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27869000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
70421000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
62439000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6990000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6191000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26386000
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
31710000
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32444000
CY2019Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
427197000
CY2018Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
414683000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71934381
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70516249
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
72000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
70000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1483245000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1434780000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-468135000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-408661000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12542000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13070000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1002640000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1013119000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1565344000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1528876000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
130276000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
94560000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
258849000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
184204000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41634000
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27684000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
86311000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
54540000
CY2019Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
26616000
CY2018Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
19561000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
53020000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
39886000
CY2019Q2 us-gaap Selling Expense
SellingExpense
15832000
CY2018Q2 us-gaap Selling Expense
SellingExpense
14559000
us-gaap Selling Expense
SellingExpense
32044000
us-gaap Selling Expense
SellingExpense
28342000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16665000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14348000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32652000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27252000
CY2019Q2 tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
2019000
CY2018Q2 tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
639000
tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
3605000
tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
1684000
CY2019Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1136000
CY2018Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5800000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2148000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7369000
CY2018Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4070000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4070000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38549000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26140000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74531000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50141000
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9848000
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8046000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19448000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16299000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
152299000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
112707000
us-gaap Costs And Expenses
CostsAndExpenses
303759000
us-gaap Costs And Expenses
CostsAndExpenses
221443000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22023000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11783000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29234000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25057000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58642000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49022000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18147000
us-gaap Operating Income Loss
OperatingIncomeLoss
-44910000
us-gaap Operating Income Loss
OperatingIncomeLoss
-37239000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7211000
CY2018Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6910000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13732000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
832000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-29324000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-25079000
us-gaap Net Income Loss
NetIncomeLoss
-59474000
us-gaap Net Income Loss
NetIncomeLoss
-48941000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71721246
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62975535
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71322586
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62389902
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-29324000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-25079000
us-gaap Net Income Loss
NetIncomeLoss
-59474000
us-gaap Net Income Loss
NetIncomeLoss
-48941000
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
5000
CY2018Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
41000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
60000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
41000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4311000
CY2018Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6010000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
468000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6658000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4316000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5969000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
528000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6617000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25008000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31048000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58946000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55558000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1013119000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8854000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13523000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3788000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-30150000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1001558000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6847000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1875000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17368000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4316000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-29324000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1002640000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
558903000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8643000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7832000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-648000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-23862000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
550868000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7122000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
91392000
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1423000
CY2018Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
68564000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11059000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5969000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-25079000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
699380000
us-gaap Net Income Loss
NetIncomeLoss
-59474000
us-gaap Net Income Loss
NetIncomeLoss
-48941000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22443000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16299000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1014000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1258000
us-gaap Share Based Compensation
ShareBasedCompensation
30891000
us-gaap Share Based Compensation
ShareBasedCompensation
18891000
tdoc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-1472000
tdoc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-1258000
tdoc Accretion Of Interest
AccretionOfInterest
12347000
tdoc Accretion Of Interest
AccretionOfInterest
7627000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4070000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7237000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4027000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1251000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
540000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-74000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
73000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
374000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1371000
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
10358000
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
-287000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9133000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3812000
tdoc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-794000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2385000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
45000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1743000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17517000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1248000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2015000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2975000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
1388000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12141000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
22695000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
67970000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5500000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
5000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
11207000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
273535000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2272000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-215609000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15701000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15765000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
279126000
tdoc Contingent Consideration Fair Value Adjustment Cash Flow Impact
ContingentConsiderationFairValueAdjustmentCashFlowImpact
210000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1875000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1423000
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
-1886000
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15900000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
296814000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16429000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
63688000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-701000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
423989000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42817000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
440443000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105804000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
309000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
59000
us-gaap Interest Paid
InterestPaid
6102000
us-gaap Interest Paid
InterestPaid
4125000
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9000000.0
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7300000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Note 1. Organization and Description of Business</b></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">Teladoc, Inc. was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. Effective August 10, 2018, Teladoc, Inc. changed its corporate name to Teladoc Health, Inc. Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health” or the “Company”. The Company’s principal executive office is located in Purchase, New York. Teladoc Health is the global leader in providing virtual healthcare services with a focus on high quality, lower costs, and improved outcomes around the world.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">On July 26, 2018, Teladoc Health completed a follow-on public offering (the “July Offering”) in which the Company issued and sold 5,000,000 shares of common stock, at an issuance price of $66.28 per share. The Company received net proceeds of $330.9 million after deducting offering expenses of $0.5 million.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">On May 31, 2018, the Company completed the acquisition of Advance Medical-Health Care Management Services, S.A. (“Advance Medical”), a leading global virtual healthcare provider. See Note 4 “Business Acquisition” for additional information.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">On May 8, 2018, the Company issued, at par value, $287.5 million aggregate principal amount of 1.375% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear cash interest at a rate of 1.375% per year, payable semi-annually in arrears on May 15 and November 15 of each year. The 2025 Notes will mature on May 15, 2025. The net proceeds to the Company from the offering were $279.1 million after deducting offering costs of approximately $8.4 million. </p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
tdoc Number Of Professional Associations Consolidated As Variable Interest Entities
NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities
2
tdoc Number Of Professional Corporations Consolidated As Variable Interest Entities
NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities
14
tdoc Contract With Customer Term
ContractWithCustomerTerm
P1Y
tdoc Payment Terms
PaymentTerms
P30D
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
130276000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
94560000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
258849000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
184204000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49800000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4600000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3300000
CY2019Q2 tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
600000
CY2018Q2 tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
400000
tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
1200000
tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
1600000
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
315413000
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
76069000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
239344000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
305658000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
58264000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
247394000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6099000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5912000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5729000
CY2019Q2 tdoc Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
15048000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
40218000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7574000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
32644000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17700000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14000000.0
CY2018Q4 us-gaap Goodwill
Goodwill
737197000
CY2017Q4 us-gaap Goodwill
Goodwill
498520000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
10604000
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
250120000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
272000
CY2018 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-11443000
CY2019Q2 us-gaap Goodwill
Goodwill
748073000
CY2018Q4 us-gaap Goodwill
Goodwill
737197000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1906000
us-gaap Operating Lease Cost
OperatingLeaseCost
3867000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
242000
us-gaap Variable Lease Cost
VariableLeaseCost
468000
CY2019Q2 us-gaap Lease Cost
LeaseCost
2148000
us-gaap Lease Cost
LeaseCost
4335000
us-gaap Operating Lease Payments
OperatingLeasePayments
4042000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3389000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M20D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0650
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7430000
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1394000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1264000
CY2019Q2 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
6089000
CY2018Q4 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
6569000
CY2019Q2 tdoc Other Current Liabilities Clients Guarantees
OtherCurrentLiabilitiesClientsGuarantees
3100000
CY2018Q4 tdoc Other Current Liabilities Clients Guarantees
OtherCurrentLiabilitiesClientsGuarantees
2910000
CY2019Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
962000
CY2018Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1073000
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
872000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
883000
CY2019Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4602000
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2610000
CY2019Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
101000
CY2018Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
53000
CY2019Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1474000
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
644000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5363000
CY2019Q2 tdoc Accrued Earn Out Current
AccruedEarnOutCurrent
634000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12285000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7650000
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9325000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3145000
CY2019Q2 tdoc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
46201000
CY2018Q4 tdoc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
26801000
CY2019Q2 tdoc Line Of Credit Facility Amount Utilized For Facility Security Deposits
LineOfCreditFacilityAmountUtilizedForFacilitySecurityDeposits
1500000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17368000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11060000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30891000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18891000
tdoc Indefinite Lived Net Operating Loss Maximum Percentage Allowed To Be Netted Against Deferred Tax Liability Associated With Goodwill
IndefiniteLivedNetOperatingLossMaximumPercentageAllowedToBeNettedAgainstDeferredTaxLiabilityAssociatedWithGoodwill
0.80
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21

Files In Submission

Name View Source Status
0001558370-19-006664-index-headers.html Edgar Link pending
0001558370-19-006664-index.html Edgar Link pending
0001558370-19-006664.txt Edgar Link pending
0001558370-19-006664-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tdoc-20190630.xsd Edgar Link pending
tdoc-20190630ex101b2e204.htm Edgar Link pending
tdoc-20190630ex211700fae.htm Edgar Link pending
tdoc-20190630ex31111d2d0.htm Edgar Link pending
tdoc-20190630ex312123b7a.htm Edgar Link pending
tdoc-20190630ex321c81d7d.htm Edgar Link pending
tdoc-20190630ex32227a59b.htm Edgar Link pending
tdoc-20190630x10q.htm Edgar Link pending
tdoc-20190630x10q_htm.xml Edgar Link completed
tdoc-20190630_cal.xml Edgar Link unprocessable
tdoc-20190630_def.xml Edgar Link unprocessable
tdoc-20190630_lab.xml Edgar Link unprocessable
tdoc-20190630_pre.xml Edgar Link unprocessable